secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOHNSON & JOHNSON (JNJ)
CIK:        0000200406
Form:       8-K
Filed at:   2021-10-12T23:59:59+00:00
Accession:  0000200406-21-000063
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Paul Stoffels, Johnson & Johnson Vice Chairman and CSO, to retire Dec 31, 2021
------------------------------------------------------------------------------

- Paul Stoffels, Vice Chairman and Chief Scientific Officer, will retire effective December 31, 2021.
- Stoffels led J&J's R&D pipeline, including development of over 25 new medicines and the COVID-19 vaccine.
- Joaquin Duato, current Vice Chairman, is set to become CEO on January 3, 2022; transition for R&D teams is planned.
- Stoffels established Johnson & Johnson Innovation and JLABS network with over 700 incubating companies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/200406/000020040621000063/0000200406-21-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/200406/000020040621000063/jnj-20211012.htm
  HTML page:      https://secwatch.observer/filing/0000200406-21-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer